Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
This update presents the current average 30-year mortgage rate, providing a snapshot to guide your borrowing strategy today.
26,958 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Microsoft cutting 4,800 jobs marks a bold pivot toward AI and cloud infrastructure. The move comes with a hefty capex...
Global headlines rarely stay abroad when markets react. This article explains how geopolitical shocks can affect pers...
Developed international value stocks are trading at discounts outside the U.S., and the Fidelity International Value ...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...
Meta is pressing ahead with a sweeping AI infrastructure plan even after laying 8,000 employees. CEO Mark Zuckerberg ...
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Gen Z is increasingly skipping the driver's license in favor of rideshare options from Uber and others. The trend cou...
As markets shift in mid-2026, investors seek a practical starting point for stock exposure. The article lays out star...
Chipmakers retreat after Samsung delivers mixed earnings, triggering a broader sector reset. Intel and Applied Materi...
EQT Corp is becoming a cash machine, with free cash flow rising and margins expanding. Wall Street is warming to the ...
Shares surged after quarterly results, lifting the outlook for this dividend-paying chip stock. Analysts say the stoc...